Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity.

scientific article published on 15 July 2016

Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.ADRO.2016.07.001
P932PMC publication ID5514157
P698PubMed publication ID28740897

P50authorChristopher R. KelseyQ43215897
Nelson J ChaoQ88101634
Mitchell E HorwitzQ88550273
David RizzieriQ92624494
Ashley M EngemannQ114516171
Martha LassiterQ114516175
P2093author name stringSamantha Thomas
Sarah J Stephens
P2860cites workPulmonary function following total body irradiation (with or without lung shielding) and allogeneic peripheral blood stem cell transplantQ28236952
Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First RemissionQ28305230
Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trialsQ34608688
Long-term survival and late deaths after allogeneic hematopoietic cell transplantationQ35023409
Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasiaQ35202316
Cardiopulmonary exercise testing prior to myeloablative allo-SCT: a feasibility studyQ35892403
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.Q37370649
Cord blood transplant for acute myeloid leukaemiaQ38696346
Bone marrow transplantation as the treatment of choice for "good risk" adult patients with acute leukemiaQ41195961
Total body irradiation plus cyclophosphamide versus busulphan with cyclophosphamide as conditioning regimen for patients with leukemia undergoing allogeneic stem cell transplantation: a meta-analysisQ43200457
Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complQ43629955
Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studiesQ43819615
Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remissionQ44242611
Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemiaQ46510867
Severe pulmonary toxicity after myeloablative conditioning using total body irradiation: an assessment of risk factors.Q51749077
Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle OsseQ68126425
A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group stQ70656728
A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for BQ71127546
A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation GroupQ72384744
Factors affecting the outcome of allogeneic bone marrow transplantation for adult patients with refractory or relapsed acute leukaemiaQ73231074
Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow TransQ74632699
Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan/cyclophosphamide vs total body irradiation: a meta-analysisQ77227206
Acute myeloid leukemiaQ83584384
P433issue4
P304page(s)272-280
P577publication date2016-07-15
P1433published inAdvances in radiation oncologyQ27727236
P1476titleMyeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity
P478volume1